156 related articles for article (PubMed ID: 37792507)
21. Targeted drug delivery for boron neutron capture therapy.
Mehta SC; Lu DR
Pharm Res; 1996 Mar; 13(3):344-51. PubMed ID: 8692724
[TBL] [Abstract][Full Text] [Related]
22. Boron lipid-based liposomal boron delivery system for neutron capture therapy: recent development and future perspective.
Nakamura H
Future Med Chem; 2013 Apr; 5(6):715-30. PubMed ID: 23617433
[TBL] [Abstract][Full Text] [Related]
23. Boron neutron capture therapy of cancer: current status and future prospects.
Barth RF; Coderre JA; Vicente MG; Blue TE
Clin Cancer Res; 2005 Jun; 11(11):3987-4002. PubMed ID: 15930333
[TBL] [Abstract][Full Text] [Related]
24. HER-2-targeted boron neutron capture therapy using an antibody-conjugated boron nitride nanotube/β-1,3-glucan complex.
Yamana K; Kawasaki R; Kondo K; Hirano H; Kawamura S; Sanada Y; Bando K; Tabata A; Azuma H; Takata T; Sakurai Y; Tanaka H; Kodama T; Kawamoto S; Nagasaki T; Ikeda A
Nanoscale Adv; 2023 Jul; 5(15):3857-3861. PubMed ID: 37496630
[TBL] [Abstract][Full Text] [Related]
25. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer.
Barth RF; Vicente MG; Harling OK; Kiger WS; Riley KJ; Binns PJ; Wagner FM; Suzuki M; Aihara T; Kato I; Kawabata S
Radiat Oncol; 2012 Aug; 7():146. PubMed ID: 22929110
[TBL] [Abstract][Full Text] [Related]
26. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
[TBL] [Abstract][Full Text] [Related]
27. From Nuclear Reactor-Based to Proton Accelerator-Based Therapy: The Finnish Boron Neutron Capture Therapy Experience.
Porra L; Wendland L; Seppälä T; Koivunoro H; Revitzer H; Tervonen J; Kankaanranta L; Anttonen A; Tenhunen M; Joensuu H
Cancer Biother Radiopharm; 2023 Apr; 38(3):184-191. PubMed ID: 36269660
[TBL] [Abstract][Full Text] [Related]
28. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex.
Coderre JA; Button TM; Micca PL; Fisher CD; Nawrocky MM; Liu HB
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):643-52. PubMed ID: 7928496
[TBL] [Abstract][Full Text] [Related]
29. A transdermal drug delivery system based on dissolving microneedles for boron neutron capture therapy of melanoma.
Li J; Wang X; Wang Z; Zhao Y; Zhang Z; Li L; Ding D; Guo J; Zhang J; Liu H; Li Z
Biomater Sci; 2023 Nov; 11(23):7568-7578. PubMed ID: 37861462
[TBL] [Abstract][Full Text] [Related]
30. Asialoglycoprotein receptor targeted micelles containing carborane clusters for effective boron neutron capture therapy of hepatocellular carcinoma.
Zhang T; Li G; Li S; Wang Z; He D; Wang Y; Zhang J; Li J; Bai Z; Zhang Q; Liu B; Zhao Q; Liu Y; Zhang H
Colloids Surf B Biointerfaces; 2019 Oct; 182():110397. PubMed ID: 31357127
[TBL] [Abstract][Full Text] [Related]
31. Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch.
Kreimann EL; Miura M; Itoiz ME; Heber E; Garavaglia RN; Batistoni D; Rebagliati RJ; Roberti MJ; Micca PL; Coderre JA; Schwint AE
Arch Oral Biol; 2003 Mar; 48(3):223-32. PubMed ID: 12648560
[TBL] [Abstract][Full Text] [Related]
32. The basis and advances in clinical application of boron neutron capture therapy.
He H; Li J; Jiang P; Tian S; Wang H; Fan R; Liu J; Yang Y; Liu Z; Wang J
Radiat Oncol; 2021 Nov; 16(1):216. PubMed ID: 34743756
[TBL] [Abstract][Full Text] [Related]
33. Phospholipid-Coated Boronic Oxide Nanoparticles as Boron Agents for Boron Neutron Capture Therapy.
Kawasaki R; Hirano H; Yamana K; Oshige A; Nishimura K; Kono N; Sanada Y; Bando K; Tabata A; Yasukawa N; Azuma H; Takata T; Sakurai Y; Tanaka H; Suzuki M; Tarutani N; Katagiri K; Nagasaki T; Ikeda A
Chembiochem; 2023 Aug; 24(15):e202300186. PubMed ID: 37069129
[TBL] [Abstract][Full Text] [Related]
34. Boron delivery for boron neutron capture therapy targeting a cancer-upregulated oligopeptide transporter.
Miyabe J; Ohgaki R; Saito K; Wei L; Quan L; Jin C; Liu X; Okuda S; Nagamori S; Ohki H; Yoshino K; Inohara H; Kanai Y
J Pharmacol Sci; 2019 Mar; 139(3):215-222. PubMed ID: 30833090
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic Study of
Watanabe T; Yoshikawa T; Tanaka H; Kinashi Y; Kashino G; Masunaga SI; Hayashi T; Uehara K; Ono K; Suzuki M
Eur J Drug Metab Pharmacokinet; 2023 Jul; 48(4):443-453. PubMed ID: 37198368
[TBL] [Abstract][Full Text] [Related]
36. Application of drug delivery system to boron neutron capture therapy for cancer.
Yanagië H; Ogata A; Sugiyama H; Eriguchi M; Takamoto S; Takahashi H
Expert Opin Drug Deliv; 2008 Apr; 5(4):427-43. PubMed ID: 18426384
[TBL] [Abstract][Full Text] [Related]
37. Boron delivery with liposomes for boron neutron capture therapy (BNCT): biodistribution studies in an experimental model of oral cancer demonstrating therapeutic potential.
Heber EM; Kueffer PJ; Lee MW; Hawthorne MF; Garabalino MA; Molinari AJ; Nigg DW; Bauer W; Hughes AM; Pozzi EC; Trivillin VA; Schwint AE
Radiat Environ Biophys; 2012 May; 51(2):195-204. PubMed ID: 22271404
[TBL] [Abstract][Full Text] [Related]
38. In vivo investigation of boron-rich nanodrugs for treating triple-negative breast cancers via boron neutron capture therapy.
Lan KW; Huang WY; Chiu YL; Hsu FT; Chien YC; Hsiau YY; Wang TW; Keng PY
Biomater Adv; 2023 Dec; 155():213699. PubMed ID: 37979440
[TBL] [Abstract][Full Text] [Related]
39. Liposome-based delivery of a boron-containing cholesteryl ester for high-LET particle-induced damage of prostate cancer cells: a boron neutron capture therapy study.
Gifford I; Vreeland W; Grdanovska S; Burgett E; Kalinich J; Vergara V; Wang CK; Maimon E; Poster D; Al-Sheikhly M
Int J Radiat Biol; 2014 Jun; 90(6):480-5. PubMed ID: 24605770
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
Kabalka GW; Smith GT; Dyke JP; Reid WS; Longford CP; Roberts TG; Reddy NK; Buonocore E; Hübner KF
J Nucl Med; 1997 Nov; 38(11):1762-7. PubMed ID: 9374349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
